Calculate Your Contrast Nephropathy Risk (Mehran Score)
Enter your eGFR value in mL/min/1.73m². (e.g., 90 for normal kidney function)
Enter the patient's age in years.
Check if the patient has experienced hypotension.
Check if an IABP is currently in use.
Check if the patient has significant heart failure.
Check if the patient has a diagnosis of diabetes.
Check if the patient has anemia based on hematocrit levels.
Enter the anticipated volume of iodinated contrast media in milliliters (mL).
What is Contrast Nephropathy?
Contrast nephropathy, more accurately termed Contrast-Induced Acute Kidney Injury (CI-AKI) or Contrast-Associated Acute Kidney Injury (CA-AKI), refers to a rapid decline in kidney function that occurs shortly after the administration of iodinated contrast media. This contrast material is commonly used in various medical imaging procedures, such as computed tomography (CT) scans, angiography, and venography, to enhance the visibility of blood vessels and organs.
The condition is typically defined as an increase in serum creatinine by at least 0.5 mg/dL (44 µmol/L) or a 25% increase from baseline within 48 to 72 hours following contrast exposure, in the absence of an alternative cause. While often transient, CI-AKI can lead to prolonged hospital stays, increased morbidity, and in severe cases, the need for renal replacement therapy (dialysis).
Who should use this Contrast Nephropathy Calculator? This calculator is designed for healthcare professionals, medical students, and patients who wish to understand the potential risk of CI-AKI associated with a planned contrast-enhanced procedure. It provides an estimate based on established risk factors and should always be used in conjunction with clinical judgment.
Common Misunderstandings (including unit confusion): A common misconception is that any rise in creatinine after contrast is due to CI-AKI. Other factors like dehydration, certain medications, or other medical conditions can also affect kidney function. Regarding units, eGFR (estimated Glomerular Filtration Rate) is typically reported in mL/min/1.73m², which is the standard unit used in this calculator. Contrast volume is measured in milliliters (mL). It's crucial to use the correct units to ensure accurate risk assessment for contrast nephropathy.
Contrast Nephropathy Calculator Formula and Explanation
This calculator utilizes the Mehran Risk Score, a validated clinical risk stratification tool developed for patients undergoing percutaneous coronary intervention (PCI) with contrast administration. The score assigns points based on various clinical factors, summing them to determine an overall risk score. This score then correlates with the predicted incidence of CI-AKI and the need for dialysis.
Mehran Risk Score Variables and Points:
| Variable | Meaning | Unit | Points | Typical Range/Condition |
|---|---|---|---|---|
| Hypotension | Systolic BP < 80 mmHg for ≥1 hr or requiring inotropic support | Unitless (Yes/No) | 5 | Present/Absent |
| IABP use | Intra-Aortic Balloon Pump in use | Unitless (Yes/No) | 5 | Present/Absent |
| Congestive Heart Failure | NYHA Class III/IV or history of pulmonary edema | Unitless (Yes/No) | 5 | Present/Absent |
| Age > 75 years | Patient's age is greater than 75 years | Years | 4 | > 75 |
| Anemia | Hematocrit < 39% (men) or < 36% (women) | Unitless (Yes/No) | 3 | Present/Absent |
| Diabetes Mellitus | Diagnosis of diabetes | Unitless (Yes/No) | 3 | Present/Absent |
| eGFR | Estimated Glomerular Filtration Rate (kidney function) | mL/min/1.73m² | 2 | 40-60 |
| 4 | 20-40 | |||
| 6 | < 20 | |||
| Contrast Media Volume | Volume of iodinated contrast administered | mL | 3 | 100-200 |
| 5 | > 200 |
The total Mehran score is the sum of points from all applicable risk factors. This score is then used to stratify the risk of CI-AKI and the need for dialysis:
- Low Risk: Mehran Score ≤ 5 (CI-AKI incidence ~7.5%, Dialysis ~0.04%)
- Moderate Risk: Mehran Score 6-10 (CI-AKI incidence ~14%, Dialysis ~0.12%)
- High Risk: Mehran Score 11-15 (CI-AKI incidence ~26%, Dialysis ~1.09%)
- Very High Risk: Mehran Score ≥ 16 (CI-AKI incidence ~57%, Dialysis ~3.6%)
Practical Examples for Contrast Nephropathy Risk
Example 1: Low Risk Scenario
A 55-year-old male patient with no significant medical history is scheduled for a diagnostic CT scan requiring 80 mL of contrast. His eGFR is 95 mL/min/1.73m².
- Inputs:
- eGFR: 95 mL/min/1.73m² (0 points)
- Age: 55 years (0 points, not > 75)
- Hypotension: No (0 points)
- IABP use: No (0 points)
- Congestive Heart Failure: No (0 points)
- Diabetes Mellitus: No (0 points)
- Anemia: No (0 points)
- Contrast Volume: 80 mL (0 points, not ≥ 100)
- Calculated Mehran Score: 0 points
- Results: Low Risk. Estimated CI-AKI Incidence: ~7.5%, Estimated Dialysis Risk: ~0.04%.
This patient has a very low risk of developing contrast nephropathy.
Example 2: High Risk Scenario
An 80-year-old female patient with a history of diabetes, congestive heart failure (NYHA Class III), and an eGFR of 35 mL/min/1.73m² is undergoing a complex angiography requiring 150 mL of contrast. She also has anemia.
- Inputs:
- eGFR: 35 mL/min/1.73m² (4 points, eGFR 20-40)
- Age: 80 years (4 points, > 75)
- Hypotension: No (0 points)
- IABP use: No (0 points)
- Congestive Heart Failure: Yes (5 points)
- Diabetes Mellitus: Yes (3 points)
- Anemia: Yes (3 points)
- Contrast Volume: 150 mL (3 points, 100-200 mL)
- Calculated Mehran Score: 4 + 4 + 5 + 3 + 3 + 3 = 22 points
- Results: Very High Risk. Estimated CI-AKI Incidence: ~57%, Estimated Dialysis Risk: ~3.6%.
This patient is at a very high risk for contrast nephropathy, necessitating aggressive preventative measures and close monitoring.
How to Use This Contrast Nephropathy Calculator
Using our renal function calculator is straightforward:
- Gather Patient Data: Obtain the patient's eGFR, age, and determine the presence of hypotension, IABP use, congestive heart failure, diabetes mellitus, and anemia.
- Input Values: Enter the numerical values for eGFR and age into the respective fields. Check the boxes for any present comorbidities or conditions.
- Specify Contrast Volume: Input the planned or estimated volume of iodinated contrast media in milliliters (mL).
- Calculate: Click the "Calculate Risk" button. The calculator will instantly display the Mehran Score, the corresponding risk category (Low, Moderate, High, Very High), and the estimated incidence of CI-AKI and dialysis risk.
- Interpret Results: Review the results. A higher Mehran score indicates a greater risk for contrast nephropathy. The accompanying text provides context for interpreting the incidence and dialysis risks.
- Reset: If you need to perform a new calculation, click the "Reset" button to clear all fields and restore default values.
- Copy Results: Use the "Copy Results" button to quickly copy the calculated risk and associated details for documentation or sharing.
How to select correct units: This calculator primarily uses eGFR in mL/min/1.73m² and contrast volume in mL, which are the standard units for the Mehran score. Ensure your input values correspond to these units. If you only have serum creatinine, you would first need to calculate eGFR using a separate eGFR calculator.
How to interpret results: The results provide a statistical probability based on the Mehran score. A "High Risk" doesn't guarantee CI-AKI, but it signals the need for heightened vigilance and preventative strategies for contrast nephropathy. Conversely, "Low Risk" reduces concern but doesn't entirely eliminate the possibility of CI-AKI.
Key Factors That Affect Contrast Nephropathy
Several factors significantly influence a patient's susceptibility to contrast nephropathy. Understanding these is crucial for risk assessment and implementing preventative strategies:
- Pre-existing Chronic Kidney Disease (CKD): This is the most potent risk factor. Patients with lower baseline eGFR values (indicating poorer kidney function) are at a substantially higher risk. The Mehran score assigns more points as eGFR decreases.
- Diabetes Mellitus: Diabetic patients are more prone to microvascular complications, including kidney disease, making them more vulnerable to CI-AKI. The score accounts for this with specific points.
- Congestive Heart Failure (CHF): Patients with severe heart failure often have reduced renal perfusion and are more susceptible to kidney injury. This condition adds significant points to the Mehran score.
- Hypotension: Periods of low blood pressure during or after the procedure can further compromise renal blood flow, exacerbating the risk of kidney damage from contrast agents.
- Intra-Aortic Balloon Pump (IABP) Use: This indicates severe cardiac instability and is associated with a higher risk of CI-AKI, likely due to underlying critical illness and reduced renal perfusion.
- Advanced Age (> 75 years): Older patients generally have a reduced physiological reserve and may have age-related decline in kidney function, increasing their vulnerability to contrast nephropathy.
- Anemia: Low red blood cell count can contribute to reduced oxygen delivery to tissues, including the kidneys, making them more susceptible to injury.
- Contrast Media Volume: A higher volume of contrast agent is directly correlated with an increased risk of CI-AKI due to a greater nephrotoxic load. The Mehran score gives more points for larger volumes.
- Type of Contrast and Administration Route: High-osmolality contrast agents are more nephrotoxic than iso-osmolar or low-osmolar agents. Arterial administration (e.g., during angiography) generally carries a higher risk than venous administration. This calculator focuses on risk factors, not contrast type directly, but is an important clinical consideration.
- Concomitant Nephrotoxic Drugs: Concurrent use of medications like NSAIDs, certain antibiotics, or diuretics can compound the risk of kidney injury.
Frequently Asked Questions (FAQ) about Contrast Nephropathy
Q: What is the primary definition of Contrast-Induced Acute Kidney Injury (CI-AKI)?
A: CI-AKI is typically defined as an acute decline in kidney function (increase in serum creatinine by ≥0.5 mg/dL or ≥25% from baseline) within 48-72 hours after exposure to iodinated contrast media, without another identifiable cause.
Q: Is Contrast Nephropathy always permanent?
A: No, in most cases, CI-AKI is transient and kidney function recovers within days to weeks. However, in a subset of patients, it can lead to persistent kidney dysfunction or, rarely, require permanent dialysis.
Q: What are common symptoms of CI-AKI?
A: CI-AKI often has no specific symptoms, especially in its early stages. It is usually detected through blood tests showing an increase in serum creatinine. In severe cases, symptoms of fluid overload or uremia might appear.
Q: How can I prevent contrast nephropathy?
A: Prevention strategies include adequate hydration (oral or intravenous fluids), using the lowest possible volume of contrast media, avoiding nephrotoxic drugs, and sometimes using iso-osmolar contrast agents. For high-risk patients, careful pre-procedure assessment using tools like this contrast nephropathy calculator is essential.
Q: Why does this calculator only ask for eGFR, not serum creatinine?
A: The Mehran score, on which this calculator is based, directly uses eGFR ranges for risk stratification. While eGFR is calculated from serum creatinine, age, sex, and race, providing eGFR directly simplifies the calculator's input and ensures alignment with the score's original methodology. If you only have serum creatinine, you would need to calculate your eGFR first using a dedicated creatinine clearance calculator or eGFR calculator.
Q: What if my eGFR is extremely low or high?
A: The calculator handles a wide range of eGFR values. For eGFR < 20 mL/min/1.73m², the maximum points (6) are assigned, indicating very severe kidney impairment and highest risk. For eGFR ≥ 60 mL/min/1.73m², no points are assigned for CKD, indicating lower risk. Always consult a physician for extremely low eGFR values related to contrast nephropathy.
Q: Are there other names for Contrast Nephropathy?
A: Yes, it is also commonly referred to as Contrast-Induced Acute Kidney Injury (CI-AKI) or Contrast-Associated Acute Kidney Injury (CA-AKI). The term "contrast nephropathy" is still widely used but CI-AKI/CA-AKI are increasingly preferred for their more precise medical terminology.
Q: What are the limitations of this Contrast Nephropathy Calculator?
A: This calculator is based on the Mehran score, which was primarily validated for patients undergoing PCI. While widely applicable, its predictive power may vary in other clinical contexts or with different types of contrast procedures. It provides a risk estimate but cannot predict individual outcomes. It also does not account for all possible contributing factors or individual patient variability. Always use clinical judgment.